Drug makers call for reassessment of new drugs

Published: 2008-05-16 06:57:00

Updated: 2008-05-16 06:57:00

Representatives from Korea's two business lobby groups - the Korea Pharmaceutical Manufacturers Association and the Korea research based Pharmaceutical Industry Association held a workshop to review the government's reassessment of new antihyperlipidemic agents in terms of cost effectiveness.

...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK